Ann: Quarterly Activities Report & Appendix 4C, page-6

First 6 Last

Share
Profile

Follow
bocasubi

1,788 Posts.

281

30/01/19

10:59

Post #: 37261919
Share

Originally posted by packyourbags ↑

Main takeaway is that OOK is in advanced discussions with a fintech. Whether this is in relation to a collaboration or acquisition it is uncertain - although an acquisition would be positive due to the fact it is currently revenue producing. This is quite big news imo and could be the catalyst for share price appreciation. I find it interesting that the company decided to mention this as it is not a done deal, and they have never provided details surrounding negotiations in the past. This leads me to believe that negotiations are quite advanced and they are confident of the deal progressing.

BronID also seems to be progressing nicely and it is good to hear they are in advanced discussions with major banks. Tellingly there was no mention of BronRewards which leads me to believe that Brontech have all but pulled the plug on that one.

Capital is starting to become an issue, especially if they want to make an acquisition as dilution down here would not be favourable. However I imagine if the deal goes through, there would a pump in the share price prior to a capital raising. It is also important to remember that OOK has the Actuity facility up its sleeve which could generate significant capital, especially if there is a rise in the share price.

In regards to Akela, it is disappointing there is no roadmap to further monetise this tech now that the back end work is done. We will just have to wait and see if they can drum up some additional offers.

Expand

It's been sold off too far. This news in itself is enough for a mild rerate imo.

OOK Price at posting: 1.2¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

NHF

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

ACW

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

There are more pages in this discussion • 134 more messages in this thread...

First 6 Last

Add FL1 (ASX) to my watchlist

(20min delay)
Last 12.5¢		Change -0.020(13.8%)		Mkt cap ! $9.956M

Open	High	Low	Value	Volume
14.0¢	14.0¢	12.5¢	$8.147K	60.96K

Buyers (Bids)

No.	Vol.	Price($)
2	24835	13.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	86346	2

View Market Depth

No.	Vol.	Price($)
2	24835	0.130
1	41292	0.125
2	39000	0.115
3	128000	0.100
1	200000	0.085

Price($)	Vol.	No.
0.145	86346	2
0.150	75416	2
0.170	100000	1
0.200	64840	5
0.220	5000	1

Last trade - 13.55pm 12/11/2024 (20 minute delay)

FL1 (ASX) Chart

Ann: Quarterly Activities Report & Appendix 4C, page-6

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities Report & Appendix 4C, page-6

Top Stories

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News